Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Open-market buy Director bought 10,000 shares at $2.71 ($27,100)
  2. 4 Open-market buy Director bought 10,000 shares at $3.53 ($35,300)
  3. 4 Open-market buy Director bought 5,000 shares at $3.32 ($16,600)
  4. 4 Open-market buy Director bought 7,400 shares at $3.22 ($23,828)
  5. 4 Open-market buy Chief Executive Officer bought 20,000 shares at $2.99 ($59,800)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Other acquisition COO & CFO acquired 912 shares (other)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market buy Director bought 15,000 shares at $4.10 ($61,500)

Page 8 of 24 · 471 filings